āagman

Not investment advice. Data and computed figures, for information only.

Star Health & Allied Insurance Company Ltd

NSE: STARHEALTH
₹548.85
−₹1.15 (−0.21%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹32,498 Cr
CMP
₹548.85
52-wk High / Low
₹625 / 417
P/E
38.5
P/B
4.3
Book Value
₹129.0
Div Yield
0.00%
ROCE
10.0%
ROE
7.6%
Face Value
₹10
D/E
0.06

Price+14.4% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹166
√(22.5 × EPS × book value per share)
ROIC
6.8%
vs 10.0% sector median
Cash flow to profit
3.36
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+151
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
7.6%
ROE × earnings retention ratio
ROE stability
13.3
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.03FII +0.98DII −0.90
Latest quarter vs the previous one
Cash-accrual divergence
−5.9%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.1x)
+Annualised volatility of 23.2% is in the low band (≤25%)
Watch-outs
−Promoter holding fell by 0.3pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Standalone basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3,2933,4613,5783,6883,8164,0584,1464,0814,8804,3784,5664,6485,522
Expenses2,9093,2963,1913,5023,3913,9123,8614,0894,2924,3034,3954,5004,773
Operating Profit384165387186425147285−758875172148749
OPM %11.7%4.8%10.8%5.0%11.1%3.6%6.9%−0.2%12.0%1.7%3.8%3.2%13.6%
Other Income021312260324−8
Interest0000000000000
Depreciation0000000000000
Profit before tax384167388190426149287−158878173151742
Net Profit288125290142319111215143855128111550
EPS (₹)4.952.154.952.435.451.893.660.017.450.932.181.899.34

Profit & Loss

As of 30 Jun 2026
Standalone · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,0691,5952,0122,8883,7754,9875,05010,60212,09614,02116,10117,82519,114
Expenses1,1891,4391,8712,6733,5654,5446,44711,96211,22312,84015,18017,00117,971
Operating Profit−120156141215210443−1,397−1,3608731,1829218241,143
OPM %−11.2%9.8%7.0%7.4%5.6%8.9%−27.7%−12.8%7.2%8.4%5.7%4.6%6.0%
Other Income000000−37561291
Interest12320000000000
Depreciation1918202328294643525971790
Profit before tax−140137118171182413−1,446−1,3978261,1298617541,144
Net Profit−140137118170128268−1,086−1,041619845646557844
EPS (₹)−3.873.532.593.732.815.46−19.81−18.0810.6314.4410.999.4714.34

Balance Sheet

As of 30 Jun 2026
Standalone · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital362387456456456491548576582585588588—
Reserves−220−273345047731,1532,9474,0454,8625,7996,4716,987—
Borrowings000250250250250720470470470470—
Other Liabilities9541,0121,4232,1383,3944,2336,7568,1749,31310,91413,25516,019—
Total Liabilities1,0961,3722,2133,3474,8726,12710,50113,51415,22617,76820,78524,064—
Fixed Assets466277928590183113217159357404—
CWIP1237513121941016249—
Investments5028071,4282,1653,0304,2906,73311,37313,27615,49117,70319,780—
Other Assets5355007001,0851,7441,7353,5652,0241,7232,1022,7013,871—
Total Assets1,0961,3722,2133,3474,8726,12710,50113,51415,22617,76820,78524,064—

Cash Flows

As of 31 Mar 2026
Standalone · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity——321557776647890561,2761,3101,3791,873
Cash from Investing Activity——−497−663−731−1,006−2,418−3,786−1,097−1,177−1,151−1,067
Cash from Financing Activity——3102493331222,6132,509−26823−4−31
Net Cash Flow——134143379−2371,086−1,221−89156224775

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—55.021.019.014.025.0−51.0−31.015.018.012.010.0
ROE %———————————7.6
EPS (₹)−3.873.532.593.732.815.46−19.81−18.0810.6314.4410.999.47
Book Value (₹)———————————129.0
Face Value (₹)———————————10
P/E———————————38.5
Div Yield %———————————0.00
NPM %−13.18.65.95.93.45.4−21.5−9.85.16.04.03.1
OPM %−11.010.07.07.06.09.0−28.0−13.07.08.06.04.6
D/E0.000.000.000.260.200.150.070.160.090.070.070.06
P/B———————————4.3

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+27.0%
5 years+29.0%
3 years+14.0%
TTM+11.0%
Compounded profit growth
10 years+15.0%
5 years+20.0%
3 years−3.0%
TTM+10.0%
Stock price CAGR
3 years−2.0%
Last year+15.0%
Return on equity
10 years3.0%
5 years6.0%
3 years10.0%
Last year8.0%

Shareholding pattern

As of 31 Dec 2024
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters58.90%58.90%58.29%57.92%57.67%57.98%58.01%
FIIs9.78%9.78%35.24%26.57%18.69%15.06%16.04%
DIIs27.30%27.30%1.44%11.14%15.44%20.31%19.41%
Government———————
Public4.02%4.02%5.02%4.38%8.22%6.66%6.55%
No. of shareholders1,79,0691,79,0691,64,9121,75,2982,21,6121,79,0671,68,763
Change since Jun 2023 (pp)
Promoters −0.89FIIs +6.26DIIs −7.89Public +2.53

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Announcement under Regulation 30 (LODR)-Credit RatingDisclosure Under Regulation 31A Of SEBI (LODR) Regulations 2015Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026Closure of Trading Window
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Jul 2026PPTJul 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingApr 2026PPTFeb 2026TranscriptFeb 2026PPTNov 2025TranscriptNov 2025PPTNov 2025Recording

Corporate actions

Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman